Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers

OBJECTIVE: To compare the efficacy and safety of a new combination Diskus inhaler containing both salmeterol 50 μg and fluticasone propionate 250 μg (Seretide) with the two drugs delivered via separate Diskus inhalers.

Saved in:
Bibliographic Details
Main Authors: Kenneth R Chapman, Nils Ringdal, Vibeke Backer, Mona Palmqvist, Seppo Saarelainen, Mark Briggs
Format: Article
Language:English
Published: Wiley 1999-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/1999/894803
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561215686049792
author Kenneth R Chapman
Nils Ringdal
Vibeke Backer
Mona Palmqvist
Seppo Saarelainen
Mark Briggs
author_facet Kenneth R Chapman
Nils Ringdal
Vibeke Backer
Mona Palmqvist
Seppo Saarelainen
Mark Briggs
author_sort Kenneth R Chapman
collection DOAJ
description OBJECTIVE: To compare the efficacy and safety of a new combination Diskus inhaler containing both salmeterol 50 μg and fluticasone propionate 250 μg (Seretide) with the two drugs delivered via separate Diskus inhalers.
format Article
id doaj-art-54fce0c03d184af28f1443a65b4a77ba
institution Kabale University
issn 1198-2241
language English
publishDate 1999-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-54fce0c03d184af28f1443a65b4a77ba2025-02-03T01:25:40ZengWileyCanadian Respiratory Journal1198-22411999-01-0161455110.1155/1999/894803Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus InhalersKenneth R Chapman0Nils Ringdal1Vibeke Backer2Mona Palmqvist3Seppo Saarelainen4Mark Briggs5Toronto Hospital (Western Division), Toronto, Ontario, CanadaMolde Hospital, Molde, NorwayDepartment of Internal Medicine, Lung Division, Bispebjerg Hospital, Copenhagen, DenmarkAsthma and Allergy Centre, Sahlgrenska University Hospital, Gothenberg, SwedenTampere University Hospital, Pikonlinna Hospital, Pikonlinna, FinlandRespiratory Clinical Research, GlaxoWellcome Research and Development, Greenford, Middlesex, UKOBJECTIVE: To compare the efficacy and safety of a new combination Diskus inhaler containing both salmeterol 50 μg and fluticasone propionate 250 μg (Seretide) with the two drugs delivered via separate Diskus inhalers.http://dx.doi.org/10.1155/1999/894803
spellingShingle Kenneth R Chapman
Nils Ringdal
Vibeke Backer
Mona Palmqvist
Seppo Saarelainen
Mark Briggs
Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
Canadian Respiratory Journal
title Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
title_full Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
title_fullStr Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
title_full_unstemmed Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
title_short Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers
title_sort salmeterol and fluticasone propionate 50 250 μg administered via combination diskus inhaler as effective as when given via separate diskus inhalers
url http://dx.doi.org/10.1155/1999/894803
work_keys_str_mv AT kennethrchapman salmeterolandfluticasonepropionate50250mgadministeredviacombinationdiskusinhaleraseffectiveaswhengivenviaseparatediskusinhalers
AT nilsringdal salmeterolandfluticasonepropionate50250mgadministeredviacombinationdiskusinhaleraseffectiveaswhengivenviaseparatediskusinhalers
AT vibekebacker salmeterolandfluticasonepropionate50250mgadministeredviacombinationdiskusinhaleraseffectiveaswhengivenviaseparatediskusinhalers
AT monapalmqvist salmeterolandfluticasonepropionate50250mgadministeredviacombinationdiskusinhaleraseffectiveaswhengivenviaseparatediskusinhalers
AT sepposaarelainen salmeterolandfluticasonepropionate50250mgadministeredviacombinationdiskusinhaleraseffectiveaswhengivenviaseparatediskusinhalers
AT markbriggs salmeterolandfluticasonepropionate50250mgadministeredviacombinationdiskusinhaleraseffectiveaswhengivenviaseparatediskusinhalers